Loretha Myers

8.7k total citations · 2 hit papers
16 papers, 4.6k citations indexed

About

Loretha Myers is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Loretha Myers has authored 16 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Loretha Myers's work include Connective tissue disorders research (15 papers), Aortic Disease and Treatment Approaches (8 papers) and Cardiac Valve Diseases and Treatments (3 papers). Loretha Myers is often cited by papers focused on Connective tissue disorders research (15 papers), Aortic Disease and Treatment Approaches (8 papers) and Cardiac Valve Diseases and Treatments (3 papers). Loretha Myers collaborates with scholars based in United States, Australia and Switzerland. Loretha Myers's co-authors include Harry C. Dietz, Daniel P. Judge, Francesco Ramirez, Lynn Y. Sakai, Enid Neptune, Barbara Gayraud-Morel, Tracie E. Bunton, David L. Huso, Djahida Bedja and Nancy Jensen Biery and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Loretha Myers

16 papers receiving 4.5k citations

Hit Papers

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in ... 2003 2026 2010 2018 2006 2003 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loretha Myers United States 14 3.0k 2.3k 1.5k 1.0k 659 16 4.6k
Jennifer Habashi United States 15 2.1k 0.7× 2.0k 0.9× 1.3k 0.9× 959 0.9× 609 0.9× 23 3.9k
Tammy M. Holm United States 14 1.6k 0.5× 1.4k 0.6× 889 0.6× 885 0.9× 505 0.8× 27 3.2k
Luca Carta United States 14 1.6k 0.5× 1.2k 0.5× 666 0.4× 592 0.6× 315 0.5× 22 2.5k
Nancy Jensen Biery United States 7 1.3k 0.4× 931 0.4× 458 0.3× 319 0.3× 177 0.3× 7 1.7k
Claude Turc‐Carel France 37 654 0.2× 3.9k 1.7× 801 0.5× 2.9k 2.8× 583 0.9× 90 7.2k
Mohamad Azhar United States 27 363 0.1× 547 0.2× 612 0.4× 1.5k 1.4× 443 0.7× 53 2.6k
Ann Pieczek United States 18 407 0.1× 513 0.2× 464 0.3× 2.2k 2.1× 1.6k 2.5× 25 3.6k
Jonathan Berg United Kingdom 23 364 0.1× 1.4k 0.6× 197 0.1× 911 0.9× 637 1.0× 43 2.9k
Per Levéen Sweden 19 387 0.1× 801 0.3× 158 0.1× 2.7k 2.7× 645 1.0× 26 4.5k
Marie K. Schluterman United States 7 526 0.2× 644 0.3× 690 0.5× 1.6k 1.6× 286 0.4× 8 2.3k

Countries citing papers authored by Loretha Myers

Since Specialization
Citations

This map shows the geographic impact of Loretha Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretha Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretha Myers more than expected).

Fields of papers citing papers by Loretha Myers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretha Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretha Myers. The network helps show where Loretha Myers may publish in the future.

Co-authorship network of co-authors of Loretha Myers

This figure shows the co-authorship network connecting the top 25 collaborators of Loretha Myers. A scholar is included among the top collaborators of Loretha Myers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loretha Myers. Loretha Myers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rouf, Rosanne, Elena Gallo MacFarlane, Eiki Takimoto, et al.. (2017). Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice. JCI Insight. 2(15). 43 indexed citations
2.
Doyle, Jefferson J., Alexander Doyle, Jennifer Habashi, et al.. (2015). A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. eLife. 4. 74 indexed citations
3.
Doyle, Jefferson J., Alexander Doyle, Jennifer Habashi, et al.. (2014). Abstract 18126: Calcium Channel Blockers Accelerate Aortic Aneurysm and Cause Premature Lethality in Marfan Syndrome and Related Conditions. 130. 1 indexed citations
4.
Gallo, Elena, David Loch, Jennifer Habashi, et al.. (2013). Angiotensin II–dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. Journal of Clinical Investigation. 124(1). 448–460. 183 indexed citations
5.
Frischmeyer‐Guerrerio, Pamela A., Anthony L. Guerrerio, Gretchen Oswald, et al.. (2013). TGFβ Receptor Mutations Impose a Strong Predisposition for Human Allergic Disease. Science Translational Medicine. 5(195). 195ra94–195ra94. 151 indexed citations
6.
Cooper, Timothy K., Qing Zhong, Melissa Krawczyk, et al.. (2010). The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome. Veterinary Pathology. 47(6). 1028–1039. 33 indexed citations
7.
Hanada, Katsuhiro, Marcel Vermeij, George A. Garinis, et al.. (2007). Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice. Circulation Research. 100(5). 738–746. 123 indexed citations
8.
Habashi, Jennifer, Daniel P. Judge, Tammy M. Holm, et al.. (2006). Losartan in Marfan Syndrome—Beyond Blood Pressure Lowering. Journal of the American Society of Nephrology. 17(7). 1759–1764. 3 indexed citations
9.
Habashi, Jennifer, Daniel P. Judge, Tammy M. Holm, et al.. (2006). Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome. Science. 312(5770). 117–121. 1252 indexed citations breakdown →
10.
Jones, Kevin B., Loretha Myers, Daniel P. Judge, et al.. (2005). Toward an Understanding of Dural Ectasia: A Light Microscopy Study in a Murine Model of Marfan Syndrome. Spine. 30(3). 291–293. 45 indexed citations
11.
Cheng, Alan, Loretha Myers, Francisco Martínez-Murillo, et al.. (2004). TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. Journal of Clinical Investigation. 114(11). 1586–1592. 360 indexed citations
12.
Cheng, Alan, Loretha Myers, Francisco Martínez-Murillo, et al.. (2004). TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. Journal of Clinical Investigation. 114(11). 1586–1592. 403 indexed citations
13.
Judge, Daniel P., Nancy Jensen Biery, Douglas R. Keene, et al.. (2004). Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. Journal of Clinical Investigation. 114(2). 172–181. 315 indexed citations
14.
Judge, Daniel P., Nancy Jensen Biery, Douglas R. Keene, et al.. (2004). Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. Journal of Clinical Investigation. 114(2). 172–181. 281 indexed citations
15.
Neptune, Enid, Dan E. Arking, Loretha Myers, et al.. (2003). Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nature Genetics. 33(3). 407–411. 1038 indexed citations breakdown →
16.
Bunton, Tracie E., Nancy Jensen Biery, Loretha Myers, et al.. (2001). Phenotypic Alteration of Vascular Smooth Muscle Cells Precedes Elastolysis in a Mouse Model of Marfan Syndrome. Circulation Research. 88(1). 37–43. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026